Proudly Based in Canada | Premium Research Peptides for Modern Science
Free Shipping on Orders Over $300 CAD
Every civilization has left behind evidence of the same enduring question.
Ancient rulers sought mythical springs said to restore youth. Alchemists searched for elixirs capable of extending life. Physicians, philosophers, and scholars debated why the body changes with age and whether those changes could ever be understood. While the methods differed, the question remained remarkably consistent:
Why do we age?
For most of human history, aging was accepted as an unavoidable fact of life. People could observe it, measure it, and describe it, but they could not explain it. Time moved forward. Children became adults. Adults grew old. The process seemed as natural and inevitable as the changing of the seasons.
As science advanced, however, the question began to change.
Researchers stopped asking how to escape aging and began asking what aging actually was. Was it simply the accumulation of damage? Was it the gradual failure of biological systems? Was it programmed into our biology, or was it the consequence of countless processes unfolding over time?
Each generation of scientists offered new answers. Some theories reshaped entire fields of research. Others were eventually challenged or replaced. Yet with every discovery, the mystery grew more complex.
One of the most important realizations was that the human body does not operate randomly. Nearly every biological process follows a rhythm. Sleep and wake cycles, hormone release, body temperature, metabolism, and cellular activity all rise and fall according to internal schedules. Beneath the surface of everyday life, the body appears to keep time.
This insight transformed how scientists thought about aging.
If biological systems operate according to rhythms and timing signals, could aging itself be connected to those same mechanisms? Could the passage of biological time be measured, influenced, or better understood? And if so, where should researchers begin looking?
Those questions would eventually lead scientists toward one of the most mysterious structures in the human body: a tiny gland buried deep within the brain known as the pineal gland.
For some researchers, the pineal gland represented more than just another organ. It appeared to sit at the intersection of sleep, circadian rhythm, hormonal regulation, and biological timing. If the body possessed an internal clock, the pineal gland seemed a likely place to begin searching for its mechanisms.
Among the scientists drawn to this challenge was Russian gerontologist Vladimir Khavinson. Over the course of several decades, Khavinson and his colleagues would pursue a controversial and ambitious idea: that small peptide signals might play a role in regulating biological function and aging itself.
That search would eventually lead to the development of a peptide known as Epitalon.
Yet the story of Epitalon is not simply the story of a peptide.
It is the story of a scientific journey spanning generations. It is the story of changing theories, unexpected discoveries, unanswered questions, and the evolving effort to understand one of biology’s greatest mysteries.
Not how to defeat time.
But how time works.
And in many ways, that search continues today.
For most of human history, aging was viewed as an unavoidable consequence of living. People observed the gradual changes that occurred with time but had little understanding of the biological mechanisms behind them. Hair turned grey, strength declined, wounds healed more slowly, and the body became increasingly vulnerable to disease. These changes appeared so universal that they were often accepted as natural laws rather than scientific mysteries. While philosophers debated the meaning of growing old and physicians attempted to treat its symptoms, few possessed the tools necessary to investigate the process itself.
As scientific knowledge expanded during the nineteenth and twentieth centuries, researchers began searching for physical explanations. Early theories suggested that aging was simply the result of accumulated wear and tear, much like a machine gradually deteriorating through repeated use. Others proposed that toxic byproducts of metabolism slowly damaged tissues over time, while some researchers believed that aging resulted from hormonal decline or the gradual exhaustion of the body’s regenerative capacity. Each theory provided useful insights, but none could fully explain the remarkable complexity of aging. The deeper scientists looked, the more they realized that no single mechanism appeared capable of accounting for the entire process.
One of the most significant shifts occurred when researchers began studying biological rhythms. Rather than operating continuously, many functions of the human body followed predictable cycles. Sleep and wake patterns, hormone production, body temperature, metabolism, and countless cellular activities all rose and fell according to internal schedules. These rhythms persisted even when external conditions changed, suggesting that living organisms possessed internal timing systems capable of coordinating biological activity. The body was not merely reacting to the environment; it appeared to be keeping time.
This realization transformed how scientists viewed aging. If biological systems depended upon coordinated timing signals, perhaps aging was not simply the accumulation of damage but also a gradual loss of coordination. The analogy of an orchestra became increasingly useful. In youth, countless biological systems perform in harmony, responding to signals with remarkable precision. As time passes, that coordination may begin to weaken. Hormonal rhythms become less predictable, sleep patterns change, cellular repair mechanisms become less efficient, and communication between biological systems may gradually deteriorate. Aging, in this view, was not simply deterioration but a complex disruption of timing and regulation.
These ideas naturally led researchers toward structures believed to play important roles in biological timing. Among them was the pineal gland, a small organ located near the center of the brain. For centuries the pineal gland occupied an unusual place in science. Its function remained largely unknown, and speculation often exceeded evidence. Yet as research progressed, scientists discovered that the gland was involved in the production of melatonin, a signaling molecule closely associated with circadian rhythms and the regulation of sleep-wake cycles. What had once been considered an obscure anatomical curiosity suddenly became a subject of serious scientific interest.
The discovery of melatonin in the mid-twentieth century provided researchers with one of the first measurable links between the pineal gland and biological timing. Scientists could now observe how hormonal signals changed throughout the day and how those signals influenced broader physiological systems. Questions quickly followed. If the pineal gland helped regulate daily biological rhythms, could it also influence longer-term processes associated with aging? Could the body’s internal clocks affect how tissues adapt, repair, and respond over the course of a lifetime? These questions did not produce immediate answers, but they opened entirely new directions for research.
At the same time, a growing field known as gerontology was emerging. Researchers around the world were beginning to investigate aging as a scientific discipline rather than simply a medical inevitability. Within the Soviet Union, this interest developed into substantial research programs focused on longevity, adaptation, stress physiology, and the mechanisms that allow organisms to maintain function over time. Scientists increasingly viewed aging not as a single event but as the cumulative result of countless biological interactions occurring across decades. Understanding those interactions became one of the defining scientific challenges of the era.
By the latter half of the twentieth century, the search for answers had moved beyond observation and into experimentation. Researchers were no longer content to describe aging; they wanted to understand the signals, systems, and mechanisms that governed it. The pineal gland, biological rhythms, and emerging theories of cellular regulation offered promising avenues for exploration. Among the scientists drawn to these questions was Vladimir Khavinson, whose work would eventually contribute to a new line of research centered on peptide bioregulators and the possibility that small molecular signals might play a role in maintaining biological function over time.
The stage was now set for one of the most intriguing chapters in modern aging research. The question was no longer whether aging occurred. The question had become far more ambitious:
How does the body keep time, and what happens when those systems begin to change?
By the second half of the twentieth century, aging research had entered a new phase. Scientists were no longer satisfied with simply describing the effects of aging; they wanted to understand the biological mechanisms responsible for them. Advances in endocrinology, molecular biology, and physiology were revealing that the body functioned through intricate networks of signaling systems. Hormones, neurotransmitters, and cellular messengers coordinated countless biological processes, often with remarkable precision. The question facing researchers was no longer whether aging occurred, but whether the mechanisms that governed aging could be identified and studied.
Among the scientists drawn to this challenge was Vladimir Khavinson, a physician and gerontologist whose career would become closely associated with the study of biological aging and peptide regulation. Trained at the S.M. Kirov Military Medical Academy and later serving in military medicine, Khavinson entered research during a period when Soviet scientists were investing heavily in the study of adaptation, longevity, and age-related decline. Rather than viewing aging as a single disease or isolated process, many researchers within Soviet gerontology approached it as a systems problem. They sought to understand how organisms maintain stability, coordination, and function over time, and what factors contribute to the gradual breakdown of those systems.
This scientific environment proved fertile ground for new ideas. One concept that gained increasing attention was the possibility that short chains of amino acids, known as peptides, might play important regulatory roles throughout the body. Unlike larger proteins that often perform structural or enzymatic functions, peptides appeared capable of acting as biological signals, helping cells communicate and coordinate their activities. Researchers began to explore whether these small molecular messengers could influence tissue function, adaptation, and age-related processes. This emerging field would eventually become known as peptide bioregulation.
The pineal gland occupied a central place in this line of thinking. By this time, researchers had already established its connection to melatonin production and circadian rhythms, reinforcing the idea that it played an important role in biological timing. If aging involved the gradual disruption of regulatory systems, then the pineal gland appeared to offer a logical place to investigate. Scientists became increasingly interested in the possibility that substances produced within or associated with the gland might contribute to broader physiological regulation.
These investigations eventually led to the development of a pineal gland extract known as Epithalamin. Derived from animal pineal tissue, Epithalamin became the subject of extensive research within Soviet and later Russian gerontology programs. Researchers studied its potential effects on biological regulation, aging processes, and physiological adaptation. While the extract generated considerable interest, it also presented challenges common to many biological extracts. Complex mixtures can be difficult to standardize, making it challenging to determine which components are responsible for observed effects and whether results can be reproduced consistently across studies.
This challenge marked a critical turning point in the story. Rather than studying increasingly complex mixtures, researchers sought to identify and isolate the specific components they believed were biologically active. The goal was not merely to simplify the extract but to better understand the underlying mechanisms involved. By reducing a complex biological preparation to its essential signaling elements, scientists hoped to create a more standardized and reproducible tool for research.
That effort ultimately led to the development of a synthetic tetrapeptide composed of four amino acids: alanine, glutamic acid, aspartic acid, and glycine. The peptide became known as Epitalon, or Epithalon, and represented an attempt to capture a key component of the biological activity associated with Epithalamin while providing a more consistent and controllable research compound. For the first time, investigators could examine a defined peptide rather than a broad extract, opening the door to more focused experimentation.
At the time of its creation, Epitalon was not viewed as a miracle or revolutionary breakthrough. It was a research tool designed to explore larger questions about biological regulation and aging. Yet the peptide emerged during a period when scientists were increasingly interested in the relationship between cellular signaling, biological timing, and age-related change. As research expanded, Epitalon would gradually become associated with some of the most compelling and controversial questions in modern gerontology.
What began as an effort to understand the regulatory signals associated with the pineal gland was about to intersect with an entirely different area of research—one focused not on organs or hormones, but on the chromosomes contained within every cell of the human body. There, scientists believed they may have discovered one of the biological markers most closely linked to aging itself.
The next chapter of the story would introduce a new cast of characters: telomeres, telomerase, and the growing belief that the body’s internal clock might be measured at the cellular level.
The development of Epitalon marked the beginning of a new chapter rather than the conclusion of an existing one. Researchers now possessed a defined peptide that could be studied in a controlled manner, allowing them to move beyond broad biological extracts and focus on specific questions about regulation, aging, and cellular function. What followed was a period of expanding investigation that would connect Epitalon to some of the most influential theories in modern aging research.
During the late twentieth century, scientists increasingly turned their attention toward structures known as telomeres. Located at the ends of chromosomes, telomeres function as protective caps that help preserve genetic material during cell division. Each time a cell divides, telomeres gradually shorten, eventually reaching a point where normal cellular function may become compromised. This observation captured the attention of researchers because it appeared to provide a measurable biological marker associated with cellular aging. For the first time, scientists believed they might have discovered a mechanism capable of linking the passage of time to changes occurring within individual cells.
The excitement surrounding telomere research grew rapidly. Popular media often portrayed telomeres as a biological countdown timer, while researchers explored whether interventions could influence their behavior. The discovery of telomerase, an enzyme capable of maintaining or rebuilding telomeres under certain conditions, added another layer of intrigue. If telomeres were connected to aging and telomerase could influence telomeres, then understanding these systems became one of the most important objectives in gerontology. Although the reality proved more complex than many early headlines suggested, the field generated tremendous scientific interest.
It was within this environment that Epitalon entered a much larger conversation. Studies conducted by Khavinson and his colleagues reported findings suggesting that Epitalon might influence telomerase activity and affect telomere dynamics in certain laboratory settings. These observations attracted attention because they connected a peptide originally developed through pineal gland research with one of the most closely watched areas of aging science. For many researchers, the findings raised an important possibility: that biological regulation and cellular aging might be linked through mechanisms that were only beginning to be understood.
As additional investigations were conducted, the conversation expanded beyond telomeres alone. Researchers increasingly recognized that aging could not be explained by a single pathway, molecule, or biological clock. Gene expression, hormonal regulation, circadian rhythms, cellular communication, immune function, and environmental influences all appeared to contribute to the aging process. The more scientists explored the biology of aging, the more interconnected the system became. Rather than discovering a single master switch, researchers found themselves mapping a network of overlapping mechanisms that influenced one another in complex ways.
This shift transformed how many scientists viewed peptides such as Epitalon. Instead of searching for a single dramatic effect, researchers began investigating how regulatory molecules might participate within larger biological systems. The concept of peptide bioregulation suggested that small signaling molecules could influence communication between cells, tissues, and organs. While many questions remained unanswered, the theory aligned with a growing appreciation for systems biology, a field focused on understanding how multiple biological processes interact rather than studying them in isolation.
At the same time, scientific debate intensified. While some findings generated enthusiasm, others prompted calls for caution. Researchers outside Russia often noted that much of the peptide bioregulator literature remained unfamiliar to Western audiences. Questions emerged regarding replication, study design, population size, and the need for broader independent verification. These discussions were not unique to Epitalon; they reflected a broader reality within aging research, where promising findings frequently require years of additional investigation before their significance can be fully understood.
The growing debate did not diminish interest in the underlying questions. If anything, it reinforced the complexity of the field. Scientists increasingly recognized that aging was unlikely to be governed by a single mechanism. Telomeres remained important. Hormones remained important. Circadian rhythms remained important. Gene regulation remained important. Yet none of these systems appeared capable of explaining aging on their own. The search was gradually shifting away from simple answers and toward a deeper understanding of biological networks and regulation.
As the twenty-first century progressed, aging research entered a new era. Advances in genomics, molecular biology, bioinformatics, and systems science provided researchers with tools that earlier generations could scarcely imagine. Scientists could now examine patterns of gene expression, cellular communication pathways, and biological clocks with unprecedented precision. Many of the questions that inspired the development of Epitalon decades earlier remained unresolved, but the tools available to investigate them had become far more sophisticated.
In many ways, this period represented the true journey of Epitalon. The peptide had begun as a product of pineal gland research and peptide bioregulation theory, but it eventually became part of a much larger scientific conversation about how living systems maintain order across time. Along the way, it intersected with telomeres, cellular aging, biological clocks, and emerging models of systems biology. Some findings generated excitement. Others generated skepticism. Together, they contributed to an ongoing effort to understand one of biology’s most challenging mysteries.
The story was no longer simply about a peptide. It had become a story about how science evolves—through hypotheses, experiments, debate, revision, and discovery. Each new finding added another piece to the puzzle, while simultaneously revealing how much of the puzzle remained unsolved.
The legacy of Epitalon cannot be measured solely by the studies conducted in its name. Scientific history is filled with discoveries that changed the direction of research without ever becoming definitive answers themselves. In many cases, the most influential ideas are not the ones that solve a problem, but the ones that force scientists to ask better questions. In this respect, Epitalon occupies a unique place within the story of aging research.
When the peptide first emerged from the work of Vladimir Khavinson and his colleagues, the scientific world was still searching for a coherent explanation of aging. Researchers debated whether aging was driven primarily by damage, genetics, hormones, metabolism, or countless other factors. Each new theory appeared promising, yet each eventually revealed limitations. What made Epitalon different was not that it provided a final answer, but that it emerged at a moment when scientists were beginning to rethink the entire framework through which aging was understood.
For much of the twentieth century, aging was often viewed as a process of gradual deterioration. The body was compared to a machine that slowly accumulated wear until its components eventually failed. While this perspective explained certain aspects of aging, it struggled to account for the extraordinary complexity of living systems. Biological organisms do not simply wear out. They adapt, communicate, repair, compensate, and respond to changing conditions throughout life. The more researchers examined these processes, the more it became apparent that aging involved regulation as much as deterioration.
Epitalon entered the conversation at precisely this turning point. Its development was rooted in the concept of peptide bioregulation, a theory suggesting that small molecular signals may help coordinate biological function across tissues and organ systems. Whether specific hypotheses associated with the peptide ultimately prove correct is only part of the story. The broader significance lies in the fact that researchers were beginning to think about aging not as a single event, but as a network of interconnected processes operating across time. This shift in perspective would eventually influence how scientists approached everything from gene expression and circadian rhythms to cellular communication and systems biology.
The excitement surrounding telomeres during the late twentieth and early twenty-first centuries further amplified this influence. For a period, many researchers hoped that telomeres might provide a master key capable of explaining aging itself. The narrative was compelling. Telomeres shortened. Cells changed. Aging appeared to progress. Yet as research expanded, the reality proved more complicated. Telomeres mattered, but they were only one part of a much larger system. The same pattern repeated throughout aging research. Every promising discovery illuminated an important mechanism while simultaneously revealing additional layers of complexity.
In hindsight, this may represent one of the most valuable lessons associated with Epitalon and the era in which it emerged. The peptide became connected to questions that were far larger than itself. Researchers studying biological clocks discovered that timing systems interact with metabolism, immunity, and cellular repair. Scientists investigating gene regulation uncovered networks of communication extending across tissues and organs. Aging increasingly appeared less like a single pathway and more like an orchestra composed of countless interconnected instruments, each contributing to the overall performance of the organism.
The comparison is fitting because aging research itself evolved in much the same way. Early investigators often searched for a single cause. Later generations began searching for a single solution. Modern researchers are increasingly focused on understanding relationships, interactions, and systems. The journey resembles the restoration of an ancient clock. At first, scientists could only observe the hands moving across its face. Over time they uncovered gears, springs, and mechanisms hidden beneath the surface. Each discovery improved understanding, yet also revealed how much remained unseen. Epitalon became one of those discoveries—less important for what it claimed to explain than for the questions it encouraged scientists to explore.
The influence of this period can still be seen throughout contemporary aging science. Researchers continue to investigate biological clocks, cellular signaling pathways, peptide regulation, circadian rhythms, and mechanisms of age-related decline. Advances in genomics, artificial intelligence, and systems biology have provided tools that earlier generations could scarcely imagine. Yet despite these technological leaps, many of the central questions remain remarkably familiar. Why do biological systems lose coordination over time? How do cells communicate across decades of life? What determines the difference between adaptation and decline? These are the same questions that inspired researchers to investigate the pineal gland, peptide bioregulators, and ultimately Epitalon.
Perhaps the most honest assessment of Epitalon’s legacy is that it helped shift the conversation. It encouraged researchers to look beyond simple explanations and consider the possibility that aging involves layers of biological regulation that are only partially understood. It connected fields that were often studied separately, including chronobiology, endocrinology, molecular biology, and gerontology. Most importantly, it contributed to a broader scientific movement that viewed aging not as a passive process of deterioration, but as a dynamic and deeply interconnected biological phenomenon.
The legacy of Epitalon therefore extends beyond any single experiment, publication, or hypothesis. It lives within the larger scientific effort to understand how living systems maintain order across time. Some of the questions raised during its development have produced new discoveries. Others remain unresolved. Together they form part of an ongoing conversation that continues to evolve with each generation of researchers.
For a peptide born from the study of a small gland deep within the brain, that may be its most enduring contribution. It reminded scientists that aging is not simply the passage of years. It is the story of how countless biological systems communicate, adapt, and change over a lifetime—and how much there is still left to learn.
Every generation inherits the same question.
Why do we age?
The words may change. The theories may evolve. The tools may become more sophisticated. Yet the mystery itself remains remarkably persistent. Thousands of years ago, philosophers debated the nature of aging without the benefit of microscopes, genetics, or molecular biology. Today, researchers can sequence entire genomes, analyze cellular pathways in extraordinary detail, and model biological systems using artificial intelligence. Despite these advances, the central question continues to challenge every generation that attempts to answer it.
This reality is not a failure of science. It is evidence of the complexity of life itself.
One of the most important lessons to emerge from modern aging research is that biological systems are far more interconnected than anyone once imagined. Aging does not appear to originate from a single gene, a single organ, a single hormone, or a single cellular process. Instead, it emerges from countless interactions occurring across the body over time. Communication networks, repair mechanisms, biological clocks, environmental influences, genetics, and cellular signaling all contribute to a process that is both remarkably coordinated and extraordinarily complex. Every discovery has illuminated part of the mechanism while revealing additional layers that remain hidden.
This growing appreciation for complexity has transformed the direction of scientific research. Earlier generations often searched for a singular explanation capable of accounting for aging in its entirety. Modern researchers are increasingly focused on understanding systems, relationships, and interactions. Rather than looking for one master switch, they are attempting to understand the vast network of signals that allows living organisms to maintain balance across decades of life. In many ways, the search has become less about finding a single answer and more about understanding how countless pieces fit together.
The story of Epitalon exists within this larger transformation. The peptide emerged from efforts to understand biological regulation, circadian rhythms, and the role of signaling molecules within living systems. Along the way, it became associated with some of the most important conversations in aging science, including telomeres, gene regulation, cellular communication, and biological timing. Some of those connections remain active areas of investigation. Others continue to be debated. Together, they reflect the reality of scientific progress: knowledge advances through questions, experimentation, revision, and discovery rather than certainty.
Perhaps the most fitting metaphor for this journey is that of a train traveling through an immense and largely unmapped landscape. The destination is known. Every human life moves forward through time, and no scientific discovery has altered that reality. What researchers continue to study are the signals, switches, and mechanisms that influence the journey itself. Each generation contributes new observations. Each generation refines the map. Some pathways prove valuable. Others lead to dead ends. Yet every discovery leaves behind information that helps future travelers better understand the terrain ahead.
This perspective helps explain why the search for answers remains so compelling. Time is unlike any other resource humanity has ever pursued. Wealth can be accumulated. Knowledge can be shared. Technology can be improved. Entire civilizations can be rebuilt. Time alone moves in a single direction. It cannot be stored, recovered, or replaced. Perhaps this is why questions surrounding aging have fascinated philosophers, physicians, scientists, and ordinary people for centuries. To understand aging is, in some small way, to understand our relationship with time itself.
The future of aging research will almost certainly look different from the past. Advances in genomics, machine learning, systems biology, regenerative medicine, and molecular signaling continue to reveal new layers of biological complexity. Ideas that once seemed impossible are now the subject of active investigation. At the same time, history reminds us to remain cautious. Many theories that once appeared definitive were later revised. Many discoveries that generated excitement revealed only part of a much larger picture. The most successful scientists are often those willing to replace certainty with curiosity.
That lesson may be the most enduring thread connecting the many chapters of this story. From early observations of aging to the discovery of biological rhythms, from pineal gland research to peptide bioregulation, from Epithalamin to Epitalon, each step emerged from the same fundamental impulse: the desire to understand. Not to defeat nature, but to learn from it. Not to stop time, but to better comprehend the mechanisms through which life changes across time.
The story of Epitalon therefore remains unfinished.
Its significance lies not in providing a final answer to aging, but in its place within a much larger scientific journey. It represents one chapter in humanity’s ongoing effort to understand how living systems maintain order, adapt to change, and navigate the passage of time. Some of the questions that inspired its development have produced new discoveries. Others remain open for future generations to explore.
The train continues forward.
New researchers step aboard. New ideas emerge. New technologies reveal details that were once invisible. The map becomes more complete, yet the horizon continues to expand.
And somewhere beyond the next bend in the track, the next chapter of the story is already waiting to be written.
Stimulation of Telomerase Activity by the Peptide Epitalon in Human Somatic Cells
One of the most frequently cited papers associated with Epitalon. The study reported activation of telomerase and elongation of telomeres in cultured human somatic cells, contributing significantly to interest in Epitalon within longevity research.
PubMed:
https://pubmed.ncbi.nlm.nih.gov/12937682/
Peptide Regulation of Gene Expression and Aging
A series of publications exploring the theory that short peptides may influence biological regulation and gene expression within aging tissues.
PubMed Search:
https://pubmed.ncbi.nlm.nih.gov/?term=Khavinson+Morozov+peptide+aging
Isolation of Melatonin from the Pineal Gland
The landmark discovery that transformed pineal gland research and established melatonin as a measurable biological signal associated with circadian regulation.
Melatonin is isolated from bovine pineal tissue, establishing the pineal gland as a major focus of biological timing research.
Expansion of Soviet gerontology programs focused on adaptation, longevity, biological regulation, and aging.
Development of Epithalamin, a pineal gland extract used in studies of biological regulation and aging.
Creation of Epitalon (AEDG), a synthetic tetrapeptide derived from research into the active components of Epithalamin.
Publication of telomerase and telomere studies involving Epitalon, increasing international awareness of the peptide.
Growing integration of systems biology, genomics, epigenetics, and cellular signaling research into modern aging science.
The story of Epitalon spans several decades of scientific inquiry into aging, biological regulation, circadian rhythms, and peptide bioregulation. While many questions remain unresolved, the research surrounding the peptide emerged from a documented historical progression involving the pineal gland, peptide signaling, cellular aging, and the broader evolution of gerontology as a scientific discipline.
The resources below represent some of the most significant milestones, publications, institutions, and research themes associated with the development of Epitalon and the scientific questions that inspired its creation.
Stimulation of Telomerase Activity by the Peptide Epitalon in Human Somatic Cells
One of the most frequently cited papers associated with Epitalon. The study reported activation of telomerase and elongation of telomeres in cultured human somatic cells, contributing significantly to interest in Epitalon within longevity research.
PubMed:
https://pubmed.ncbi.nlm.nih.gov/12937682/
Peptide Regulation of Gene Expression and Aging
A series of publications exploring the theory that short peptides may influence biological regulation and gene expression within aging tissues.
PubMed Search:
https://pubmed.ncbi.nlm.nih.gov/?term=Khavinson+Morozov+peptide+aging
Isolation of Melatonin from the Pineal Gland
The landmark discovery that transformed pineal gland research and established melatonin as a measurable biological signal associated with circadian regulation.
Article:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5405617/
Peptide Bioregulation of Aging: Results and Prospects
A comprehensive review of peptide bioregulators, aging theories, and future research directions.
PubMed:
https://pubmed.ncbi.nlm.nih.gov/19830585/
Research exploring the potential influence of Epitalon on gene expression patterns within various tissues.
Article:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7037223/
Recent scientific reviews evaluating historical findings, ongoing investigations, and limitations of current evidence.
PubMed Search:
https://pubmed.ncbi.nlm.nih.gov/?term=Epitalon+Aging
The institution most closely associated with the development of peptide bioregulation research and the work of Vladimir Khavinson.
Website:
https://eng.gerontology.ru/
Khavinson’s alma mater and early research environment, where much of his medical and scientific training was established.
Website:
https://www.vmeda.org/
One of the most influential institutions in the development of Soviet gerontology and aging research programs.
A broad introduction to modern aging science, including cellular senescence, biological clocks, and systems biology.
National Institute on Aging:
https://www.nia.nih.gov/
An overview of the mechanisms that regulate biological timing and their relationship to health and aging.
National Center for Biotechnology Information:
https://www.ncbi.nlm.nih.gov/books/NBK550972/
An introduction to telomere biology, telomerase research, and the role of chromosomes in cellular aging.
National Human Genome Research Institute:
https://www.genome.gov/
Historical records documenting Khavinson’s academic career, institutional affiliations, and publication history.
Curriculum Vitae:
https://khavinson.info/curriculum-vitae
Publications:
https://khavinson.info/publications
Explore more peptide biographies and follow the stories behind the discoveries.
The Body Protection Compound That Defied Expectation
The Body Protection Compound That Defied Expectation
The Body Protection Compound That Defied Expectation
Ask Nova